Gerresheimer - GRRMF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$109.34
+0 (0.00%)

This chart shows the closing price for GRRMF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Gerresheimer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GRRMF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GRRMF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Gerresheimer in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $109.34.

This chart shows the closing price for GRRMF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Gerresheimer. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/20/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/18/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/18/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/17/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/11/2023BarclaysInitiated CoverageOverweight
8/14/2023Jefferies Financial GroupInitiated CoverageBuy
7/12/2023KeyCorpInitiated CoverageOverweight
3/9/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
2/20/2023Hauck and AufhaeuserUpgradeBuy$98.50
10/5/2022CheuvreuxUpgradeHold ➝ Buy
7/15/2022Credit Suisse GroupLower Target€94.00 ➝ €88.00
7/14/2022JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral€66.30 ➝ €65.50
6/30/2022Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy€115.00 ➝ €105.00
6/23/2022JPMorgan Chase & Co.Lower Target€68.90 ➝ €66.30
4/14/2022Credit Suisse GroupLower TargetOutperform ➝ Outperform€89.00 ➝ €86.00
4/12/2022JPMorgan Chase & Co.Lower Target€72.20 ➝ €68.90
3/24/2022JPMorgan Chase & Co.Boost Target€72.00 ➝ €72.20
1/25/2022JPMorgan Chase & Co.Lower Target€86.20 ➝ €80.20
10/13/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/13/2021JPMorgan Chase & Co.Reiterated RatingNeutral
10/13/2021Credit Suisse GroupReiterated RatingOutperform
9/17/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$112.00
9/17/2021JPMorgan Chase & Co.Reiterated RatingNeutral
1/29/2021DZ BankReiterated RatingBuy
1/22/2021Pareto SecuritiesDowngradeBuy ➝ Hold
10/19/2020DZ BankReiterated RatingSell
7/29/2020Berenberg BankReiterated RatingBuy
(Data available from 4/17/2019 forward)

News Sentiment Rating

0.66 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/20/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/19/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/18/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/17/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/18/2024
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/17/2024

Current Sentiment

  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Gerresheimer logo
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
Read More

Today's Range

Now: $109.34
Low: $109.34
High: $109.34

50 Day Range

MA: $108.36
Low: $97.04
High: $117.47

52 Week Range

Now: $109.34
Low: $91.00
High: $130.00

Volume

3,000 shs

Average Volume

421 shs

Market Capitalization

N/A

P/E Ratio

48.17

Dividend Yield

1.30%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Gerresheimer?

The following Wall Street sell-side analysts have issued research reports on Gerresheimer in the last year: Barclays PLC, Jefferies Financial Group Inc., and KeyCorp.
View the latest analyst ratings for GRRMF.

What is the current price target for Gerresheimer?

0 Wall Street analysts have set twelve-month price targets for Gerresheimer in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Gerresheimer in the next year.
View the latest price targets for GRRMF.

What is the current consensus analyst rating for Gerresheimer?

Gerresheimer currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GRRMF will outperform the market and that investors should add to their positions of Gerresheimer.
View the latest ratings for GRRMF.

What other companies compete with Gerresheimer?

How do I contact Gerresheimer's investor relations team?

Gerresheimer's physical mailing address is Klaus-Bungert-Strasse 4, Dusseldorf, Nordrhein-Westfalen 40468. The company's listed phone number is 49 211 6181 00. The official website for Gerresheimer is www.gerresheimer.com. Learn More about contacing Gerresheimer investor relations.